FUTURECO BIOSCIENCE S.A. – Trademark Portfolio
Entity Type: 99
FUTURECO BIOSCIENCE S.A. holds 19 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 17 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include NOFLY, BEST CURE, and FUTURECO BIOSCIENCE. The owner is based in OLERDOLA, BARCELONA.
AV. DEL CADI, 19-23, POL. IND. SANT
PERE, MOLANTA
OLERDOLA, BARCELONA 08799 , ES
Showing of trademarks Trademarks
Trademark Classifications
FUTURECO BIOSCIENCE S.A.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does FUTURECO BIOSCIENCE S.A. have?
FUTURECO BIOSCIENCE S.A. has 19 U.S. trademarks filed with the USPTO. Of these, 4 registered, 9 abandoned, 6 cancelled.
What trademark classes does FUTURECO BIOSCIENCE S.A. file in?
FUTURECO BIOSCIENCE S.A. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are FUTURECO BIOSCIENCE S.A.'s most well-known trademarks?
FUTURECO BIOSCIENCE S.A.'s registered trademark portfolio includes well-known marks such as NOFLY, BEST CURE, and FUTURECO BIOSCIENCE. These are among 4 currently registered trademarks in the portfolio.
What is FUTURECO BIOSCIENCE S.A.'s trademark registration success rate?
FUTURECO BIOSCIENCE S.A. has a 21% trademark registration rate, with 4 out of 19 resolved applications resulting in successful registration. Currently, 0 applications are pending review.